Modulation of Plet1 expression by N-Acetylglucosamine through the IL-17 A-MAPK pathway in an imiquimod-induced psoriasis mouse model
Inflammation Research · 2024
DOI: 10.1007/s00011-024-01958-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammation Research, 2024. Verfasst von Balachandar Selvakumar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Microbiota research group, Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates. bselvakum…. Hauptthemen laut MEDLINE: Psoriasis, Imiquimod, Interleukin-17, Acetylglucosamine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Psoriasis (Ps) is a chronic inflammatory disorder marked by skin plaque formation, driven by immune dysregulation and genetic factors. Despite the available treatments, incidence of Ps is increasing in the dermatology patients. Novel strategies are crucial due to current treatment limitations. The interleukin 17 (IL-17) pathway is pivotal in Ps pathogenesis, however the expression of its putative target gene placenta expressed transcript 1 (Plet1) remains unstudied in Ps. Considering the potential anti-inflammatory properties of N-Acetylglucosamine (GlcNAc), our study explored its role in modulating Plet1 expression in an imiquimod (IMQ)-induced Ps mouse model. Our data demonstarted a significant reduction of inflammation and Psoriasis Area and Severity Index (PASI) scores, downregulation of growth factors (GFs), IL-17 A, and MAPK expression after GlcNAc treatment. In addition, GlcNAc treatment reduced neutrophils, monocyte-dendritic cells (Mo-DC) and conventional T cells (Tcons) while increasing monocyte-macrophages (Mo-Macs) and regulatory T cells (Tregs). GlcNAc treatment also downregulated Plet1 overexpression in psoriatic mouse skin and in vitro, reduced proliferation and apoptosis in IL-17 A stimulated human dermal fibroblasts (HDF), along with IL-17 A and TGF-β mRNA expression. Together, these data suggest that, GlcNAc interferes with downstream mechanisms in IL-17 pathway and downregulating Plet1 expression, presenting a promising strategy for Ps treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbiota research group, Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates. bselvakumar@sharjah.ac.ae.
- Iron Biology research Group, Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates.
- Drug Delivery research group, Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates.
- Microbiota research group, Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates.
- Tissue injury and repair research group, Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates.
- Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, University of Sharjah, Sharjah, 27272, United Arab Emirates.
Zitieren
APA
Selvakumar, B., Rah, B., Jagal, J., Sekar, P., Moustafa, R., Ramakrishnan, R. K., Haider, M., Ibrahim, S. M., & Samsudin, R. (2024). Modulation of Plet1 expression by N-Acetylglucosamine through the IL-17 A-MAPK pathway in an imiquimod-induced psoriasis mouse model. Inflammation Research. https://doi.org/10.1007/s00011-024-01958-6
Vancouver
Selvakumar B, Rah B, Jagal J, Sekar P, Moustafa R, Ramakrishnan RK, et al. Modulation of Plet1 expression by N-Acetylglucosamine through the IL-17 A-MAPK pathway in an imiquimod-induced psoriasis mouse model. Inflammation Research. 2024. doi:10.1007/s00011-024-01958-6
BibTeX
@article{Selvakumar2024,
author = {Selvakumar, Balachandar and Rah, Bilal and Jagal, Jayalakshmi and Sekar, Priyadarshini and Moustafa, Raneem and Ramakrishnan, Rakhee Kizhuvappat and Haider, Mohamed and Ibrahim, Saleh Mohamed and Samsudin, Rani},
title = {Modulation of Plet1 expression by N-Acetylglucosamine through the IL-17 A-MAPK pathway in an imiquimod-induced psoriasis mouse model},
journal = {Inflammation Research},
year = {2024},
doi = {10.1007/s00011-024-01958-6}
}
EUVIMED